Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000472629 | SCV000548948 | benign | Adams-Oliver syndrome 5 | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001591091 | SCV001816217 | uncertain significance | not provided | 2024-06-27 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Genome- |
RCV000472629 | SCV002553434 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270503 | SCV002553435 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002329051 | SCV002626843 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-09-09 | criteria provided, single submitter | clinical testing | The c.4157C>T (p.P1386L) alteration is located in exon 25 (coding exon 25) of the NOTCH1 gene. This alteration results from a C to T substitution at nucleotide position 4157, causing the proline (P) at amino acid position 1386 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |